Introduction {#s1}
============

Inadequate bowel preparation is a prevalent and persistent problem in the endoscopy unit. Even with state-of-the-art split-dose bowel preparations, 15-20% of patients have inadequate preparation at the time of colonoscopy \[[@R01]\]. Inadequate preparation results in multiple clinical and economic harms, including decreased adenoma and cancer detection, repeat procedures, patient burden and increased cost \[[@R02]-[@R04]\]. Thus, a fail-safe strategy based solely on the *prevention* of inadequate preparation remains elusive. An appealing parallel strategy is *detection* of patients with inadequate bowel preparation before they incur the risk and expense of sedation and colon intubation. Such an approach could be used to rapidly triage patients with inadequate preparation to interventions, such as same-day consumption of additional preparation.

One novel technique to detect bowel preparation quality is hydrogen breath testing (HBT). This test holds theoretical appeal - fermentable substrates passing from the small bowel into a bacteria-rich colon produce hydrogen gas, which is then absorbed into the blood stream and exhaled. Exhaled hydrogen would be expected to decrease after a successful bowel preparation, potentially offering a quantifiable measure of the adequacy of bowel preparation without instrumentation. Indeed, several small studies have suggested that HBT accurately predicts preparation quality prior to colonoscopy \[[@R05]-[@R9]\]. Given the appropriate technology, HBT could even be used either to help patients tailor the amount of purgative they consume at home, or to identify patients with inadequate preparation once they reach the endoscopy unit.

We sought to systematically review the literature for studies examining the diagnostic test characteristics of HBT for inadequate bowel preparation. Through this work, we hoped to assess the quality of the existing literature on this topic and derive summary estimates of the diagnostic test characteristics of HBT for inadequate bowel preparation.

Materials and Methods {#s2}
=====================

Study selection {#s2a}
---------------

We developed a systematic search strategy with the assistance of a medical librarian (MC). We submitted our protocol to PROSPERO, an international prospective database of systematic reviews, which approved it before we commenced our search (PROSPERO 2015: CRD42015017806). We searched MEDLINE, Embase, Web of Science, the Cochrane Library, and clinicaltrials.gov from database inception to May 2016. Embase was also used to identify abstracts from meetings of the American Gastroenterology Association, the American Society of Gastrointestinal Endoscopy and the American College of Gastroenterology. Clinicaltrials.gov was searched to identify recently completed or ongoing trials. Studies were not restricted by language. The search strategy included the terms "colonoscopy", "breath test" and "hydrogen breath test", or synonyms of those terms. The full search strategy is provided in the Supplementary 1.

Studies were included if they met the following criteria: 1) testing of hydrogen breath levels with the intention of predicting bowel preparation quality; and 2) performance of colonoscopy to formally assess bowel preparation quality (the gold standard). Studies were not restricted by the bowel preparation scale, the breath testing substrate or protocol that was used.

Two physicians from our team (AS and JK) independently screened all abstracts to determine whether they met inclusion criteria. When an abstract appeared to meet inclusion criteria, the full-text article, if one existed, was reviewed. Any disagreement on inclusion was adjudicated by a third-team member (SS). For studies that appeared relevant but published only in abstract form, we contacted the authors for additional information.

Data extraction {#s2b}
---------------

A structured form was created to extract variables of interest, including study location and design, patient selection strategy, colonoscopy indication, age, gender, dietary changes, bowel purgative, timing of breath testing, substrate (e.g. lactulose, inulin, fiber), breath test analysis equipment, preparation quality scale, suggested hydrogen-level cutoffs and diagnostic test characteristics.

Quality assessment {#s2c}
------------------

Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool \[[@R10]\], which is recommended by the Cochrane handbook for the assessment of the accuracy of diagnostic tests \[[@R11]\]. This tool focuses on four domains: patient selection, index test, reference standard, and patient flow and index test timing. Two investigators (AS and JK) independently performed the quality assessment and agreed upon low, medium or high risk of bias for each study. Low risk for bias was defined as no more than two combined "unclear" or non-low (any bias greater than low risk) results in the domain assessment. Medium risk for bias was defined as three to four combined "unclear" or non-low results in the domain assessment. High risk for bias was defined as 5 or more combined "unclear" or non-low results in the domain assessment.

Role of funding sources {#s2d}
-----------------------

This work was performed without external funding.

Results {#s3}
=======

Literature search {#s3a}
-----------------

One hundred fifty-nine potentially relevant publications, including abstracts and full-text articles, were identified ([Fig. 1](#F1){ref-type="fig"}). Six unique studies met inclusion criteria, including four from full-text articles and two published only in abstract form. No additional studies were identified after reviewing the references of full-text articles or after searching for articles that subsequently cited any of the six studies.

![Flow chart of studies identified by literature search.](gr-11-361-g001){#F1}

Study characteristics {#s3b}
---------------------

The characteristics of the six studies are shown in [Table 1](#T1){ref-type="table"}. Altomare et al reported on two distinct studies in a single publication; therefore, two entries are included for this publication \[[@R05]\]. Three studies were performed in the USA, two in Italy and one in Japan. The number of patients analyzed ranged from 61 to 127. Three of the six studies did not report the colonoscopy indication \[[@R06], [@R08], [@R9]\]. The remaining studies included colonoscopies that were performed for a variety of indications, including diagnosis, screening and surveillance. A variety of pre-procedure diets were used including carbohydrate-free diet, clear liquids followed by overnight fasting or usual diet followed by overnight fast. Two studies did not comment on dietary changes \[[@R08], [@R9]\]. Three studies used a prebiotic (inulin, lactulose, FiberCon) in addition to a purgative, with the intention of enhancing the discriminating ability of hydrogen breath levels \[[@R05], [@R07], [@R9]\]. Only three studies assessed baseline hydrogen levels \[[@R05], [@R07], [@R9]\]. Five of the studies stated which HBT equipment was used, but no studies used the same equipment \[[@R05]-[@R08]\].

###### Study Characteristics

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                   Altomare group A (PEG only) \[[@R05]\]                                                                                                                                                 Altomare group B (PEG + inulin) \[[@R05]\]                                Mann et al (2003) \[[@R06]\]                                                                                                                  Urita et al (2003) \[[@R07]\]      Meyer et al (2001) \[[@R9]\]               Meyer et al (2002) \[[@R08]\]
  ------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- ------------------------------------------ ------------------------------------------------------------
  Study setting and design                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Country                                          Italy                                                                                                                                                                                  USA                                                                       Japan                                                                                                                                         USA                                USA                                        

  Study design                                     Prospective                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Colonoscopy indication                           Screening, surveillance and diagnostic                                                                                                                                                 Unstated                                                                  Diagnostic                                                                                                                                    Unstated                           Unstated                                   

  Patient selection                                Non-consecutive                                                                                                                                                                        Unstated                                                                  Consecutive                                                                                                                                   Unstated                                                                      

  Patient blinded?                                 Unstated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Endoscopist blinded?                             Yes                                                                                                                                                                                    Unstated                                                                                                                                                                                                                                                                                              

  Breath tester blinded?                           Yes                                                                                                                                                                                    Unstated                                                                                                                                                                                                                                                                                              

  Exclusion of H~2~ non-producers?                 Yes                                                                                                                                                                                    No                                                                        Included, analyzed as subgroup                                                                                                                No                                 No                                         

  Inclusion criteria                               Signs/symptoms of distal small intestinal diseases, screening or surveillance for colorectal cancer, follow up evaluation of IBD under medical therapy                                 Unstated                                                                  Diagnostic, non-emergent endoscopy                                                                                                            Unstated                           Unstated                                   

  Exclusion criteria                               History of liver, lung, heart, metabolic or neurological disease; lack of compliance, emergency colonoscopy, antibiotic or motility agent 1 month before endoscopy or recent smoking   Unstated                                                                  Renal insufficiency, ascites, heart failure, history of abdominal surgery, treatment prokinetics or antibiotics in 6 weeks before endoscopy   Unstated                           Unstated                                   

  Breath testing protocol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Baseline (pre-preparation) HBT? If yes, timing   Yes, 5 min before preparation                                                                                                                                                          No                                                                        Yes, before starting preparation after fasting                                                                                                No                                 Yes, timing unstated                       

  Timing of HBT relative to colonoscopy            5 min before colonoscopy                                                                                                                                                               Unstated                                                                  Every 15 min for 4 h before colonoscopy                                                                                                       Unstated                           Unstated                                   

  Non-hydrogen gases assessed?                     No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Substrate used                                   None                                                                                                                                                                                   Inulin                                                                    None                                                                                                                                          Lactulose                          None                                       ½ pt received 1,250 mg Fibercon the day before colonoscopy

  Equipment used                                   LactoFAN                                                                                                                                                                               Bedfont Scientific EC 60 gastrolyzer                                      TGA-2000, Teramecs                                                                                                                            MD-80 breath analyzer              Unstated                                   

  Colonoscopy protocol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Timing of colonoscopy                            9 a.m.                                                                                                                                                                                 Unstated                                                                  1 p.m.                                                                                                                                        Unstated                                                                      

  Bowel preparation scale                          Excellent/fair/poor                                                                                                                                                                    Excellent/fair/poor                                                       Excellent/fair/poor                                                                                                                           1 - 5 (best to worst)              1 - 5 (best to worst)                      

  Definition of "adequate preparation"             Unstated                                                                                                                                                                               Unstated                                                                  Excellent/fair considered "adequate"                                                                                                          Adequate=1 - 2, inadequate=3 - 5                                              

  Pre-colonoscopy dietary changes                  12 h fast before colonoscopy                                                                                                                                                           Clear-liquid diet the day before colonoscopy followed by overnight fast   "Usual diet" the day before procedure, then overnight fast before morning time preparation                                                    Unstated                                                                      

                                                   Group A:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                   11 patients fasted 1 day before colonoscopy, 31 had carbohydrates without starches 1 day before, 54 pts had no restrictions\                                                                                                                                                                                                                                                                                                                                                                 
                                                   Group B:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
                                                   No specific dietary changes                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Purgative used                                   PEG                                                                                                                                                                                    PEG                                                                       PEG                                                                                                                                           Unstated                           Fleet's phosphosoda, visicol or golytely   

  Single versus split dose preparation             Unstated                                                                                                                                                                               Single                                                                    Single                                                                                                                                        Unstated                                                                      
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Significant variation existed in the timing of HBT relative to colonoscopy. For example, Urita et al measured baseline hydrogen levels on the morning of the procedure and then every 15 min until colonoscopy was initiated. In contrast, Altomare et al measured baseline hydrogen levels 1 week prior to colonoscopy and again at 5 min before the bowel preparation and 5 min before the colonoscopy, which allowed for exclusion of H~2~ non-producers. Meyer et al did not specify the exact timing of HBT relative to the procedure.

The studies used a variety of bowel preparation regimens. Four studies used polyethylene glycol (PEG), one study used various preparations, including Fleet's phosphosoda, visicol and golytely, and one study did not state which purgative was used. No study used a standardized, validated bowel preparation scale such as the Ottawa, Aronchick or Boston Bowel Preparation scales \[[@R12]\]. Instead, four studies used excellent/fair/poor and two studies used a 1 - 5 scale, with 1 being the cleanest and 5 being the least clean.

HBT outcomes {#s3c}
------------

[Table 2](#T2){ref-type="table"} describes the HBT outcomes for each study. In five of the six studies, hydrogen breath levels were significantly different between adequately and inadequately prepared patients. Both studies by Altomare et al showed a significant reduction in hydrogen levels after preparation. Mann et al showed a significantly lower hydrogen breath level in the fair-to-excellent preparation group relative to the poor preparation group. One study by Meyer et al showed that hydrogen levels were lower in the adequately prepared group relative to the inadequate group, while a separate study by the same author did not find any difference.

###### HBT Outcomes by Study

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                 Altomare group A (PEG only) \[[@R05]\]                                                                                                             Altomare group B (PEG + inulin) \[[@R05]\]                                             Mann et al. (2003) \[[@R06]\]                                                                                                             Urita et al. (2003) \[[@R07]\]                                                                                                                           Meyer et al. (2001) \[[@R9]\]                                                                                                          Meyer et al. (2002) \[[@R08]\]
  -------------- -------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------
  HBT outcomes   Patients did HBT once (inpatient and outpatient). H~2~ level in excellent/fair versus poor was 1.4 ± 0.1 ppm versus 3.5 ± 0.2 ppm (P \< 0.001).\   Pre-prep to post-prep H~2~ levels: 23.8 ± 2.9 ppm versus 2.3 ± 0.3 ppm (P \< 0.001).   H~2~ levels were lower in the fair-to-excellent prep group (2.2 ± 0.2 ppm) relative to the poor prep group (14.5 ± 1.5 ppm, P \< 0.005)   No difference in baseline H~2~ levels between the adequate and inadequate group\                                                                         H~2~ levels were lower in the adequately prepared group (1.56 ppm) relative to the inadequately prepared group (2.11 ppm, P \< 0.05)   No difference between baseline H~2~ levels and post-prep H~2~ levels in the adequately prepared group relative to the inadequately prepared group
                 Patients did HBT twice (inpt only): H~2~ level in excellent/fair versus poor was 1.2 ± 0.3 ppm versus 3.3 ± 0.1 ppm (P = 0.005)                                                                                                                                                                                                                                                     At 90 min into preparation, the H~2~ level in the adequate group (18 ppm) was lower than the inadequate group (32 ppm) but without a reported P value\                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                     At 240 min into preparation, the H~2~ level in the adequate group (1.6 ppm) was significantly lower than in the inadequate group (43.4 ppm, P \< 0.01)                                                                                                                                          

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[Table 3](#T3){ref-type="table"} lists the suggested hydrogen cutoff level (to discriminate between adequate versus inadequate preparation), whenever reported, as well as the statistical analyses each study performed. Suggested absolute hydrogen level cutoffs to distinguish adequate from inadequate bowel preparation ranged from 3 to 10 parts per million (ppm). Depending on the cutoff value, sensitivity ranged from 72% to 100% and specificity ranged from 87% to 100%. Positive predictive value (PPV) ranged from 69% to 100%. Negative predictive value (NPV) ranged from 78% to 100%. Due to substantial variation in breath testing methods among studies, a meta-analysis was unable to be performed.

###### Statistical Analysis and Proposed Hydrogen Level Cutoffs for Poor Bowel Preparation

                                      Altomare group A (PEG only) \[[@R05]\]   Altomare group B (PEG + inulin) \[[@R05]\]   Mann et al (2003) \[[@R06]\]   Urita et al (2003) \[[@R07]\]              Meyer et al (2001) \[[@R9]\]   Meyer et al (2002) \[[@R08]\]
  ----------------------------------- ---------------------------------------- -------------------------------------------- ------------------------------ ------------------------------------------ ------------------------------ -----------------------------------
  H~2~ cutoff value suggested (ppm)   3                                        3                                            5                              10 at 90 and 240 min into prep ingestion   Unstated                       N/a since no difference was found
  Sensitivity (%)                     72                                       83                                           96.7                           100                                                                       
  Specificity (%)                     93                                       87                                           87.5                           100                                                                       
  NPV (%)                             93                                       93                                           77.8                           100                                                                       
  PPV (%)                             72                                       69                                           98.3                           100                                                                       
  AUROC/c-statistic                   Not available                            0.93                                         Not available                  Not available                                                             

Study quality and risk of study bias {#s3d}
------------------------------------

[Table 4](#T4){ref-type="table"} shows the results of the QUADAS-2 assessment. The two studies by Altomare et al were considered as one for the purposes of quality assessment since the methods were identical. The Altomare et al's and Urita et al's studies were scored as low risk for overall bias, and the Mann et al's and Meyer et al's studies were scored as medium risk for overall bias. No study had an individual domain or overall assessment as high risk for bias. The most common reasons for an escalation from low risk to medium risk for bias was lack of clarity in the reported methods. Specific examples include failure to describe whether consecutive patients or a random sample was enrolled, the interval between the colonoscopy and HBT, or whether all enrolled patients were included in the analysis.

###### QUADAS-2 \[[@R10]\] Assessment

                                  Altomare et al (both studies) \[[@R05]\]                                                                                                                                                    Mann et al (2003) \[[@R06]\]                                                                                                                                                                Urita et al (2003) \[[@R07]\]                                                                                                                                                               Meyer et al (2001) \[[@R9]\]                                                                                                                                                                Meyer et al (2002) \[[@R08]\]
  ------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Overall QUADAS-2 rating         Low risk of bias                                                                                                                                                                            Medium risk of bias                                                                                                                                                                         Low risk of bias                                                                                                                                                                            Medium risk of bias                                                                                                                                                                         Medium risk of bias
  Domain 1 (patient selection)    Unclear if selection introduced bias; overall low concern that included patients did not match the review question                                                                          Unclear if selection introduced bias; overall low concern that included patients did not match the review question                                                                          Low risk of selection introducing bias; overall low concern that included patients did not match the review question                                                                        Unclear if selection introduced bias; overall low concern that included patients did not match the review question                                                                          Unclear if selection introduced bias; overall low concern that included patients did not match the review question
  Domain 2 (index test)           Low risk that conduction or interpretation of the index test could have introduced bias; low concern that the index test, its conduct or interpretation differed from the review question   Low risk that conduction or interpretation of the index test could have introduced bias; low concern that the index test, its conduct or interpretation differed from the review question   Low risk that conduction or interpretation of the index test could have introduced bias; low concern that the index test, its conduct or interpretation differed from the review question   Low risk that conduction or interpretation of the index test could have introduced bias; low concern that the index test, its conduct or interpretation differed from the review question   Low risk that conduction or interpretation of the index test could have introduced bias; unclear concern that the index test, its conduct or interpretation differed from the review question
  Domain 3 (reference standard)   Low risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question                     Unclear risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question                 Unclear risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question                 Unclear risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question                 Unclear risk that the reference standard, its conduct or interpretation could have introduced bias; low concern regarding the target condition matching the review question
  Domain 4 (flow and timing)      Low risk that patient flow introduced bias                                                                                                                                                  Unclear risk that patient flow introduced bias                                                                                                                                              Low risk that patient flow introduced bias                                                                                                                                                  Unclear risk that patient flow introduced bias                                                                                                                                              Unclear risk that patient flow introduced bias

Discussion {#s4}
==========

Inadequate bowel preparation has been a persistent problem in endoscopy units despite incremental improvements from better formulations and timed dosing of bowel purgatives \[[@R01]\]. The clinical and economic harms associated with this problem are legion: missed cancers, repeat procedures, excess health system cost, patient inconvenience and risk, and endoscopy unit inefficiency \[[@R13]-[@R15]\]. A strategy that could detect patients who have had inadequate bowel preparation before the colonoscopy starts could stem many of the harms associated with inadequate bowel preparation. We reviewed all studies to date that have examined the performance of HBT for this purpose. We found that five of six studies demonstrated significant differences in hydrogen breath levels between adequately and inadequately prepared patients. Furthermore, multiple different breath testing protocols, involving the use of carbohydrate substrates, or none at all, were used successfully. Our systematic review suggests the future promise of hydrogen breath testing for detecting inadequate bowel preparation. With future studies clarifying a dominant strategy, the use of hydrogen breath testing may represent a possible paradigm shift for how endoscopy units identify inadequate bowel preparation prior to sedation and instrumentation.

Previous attempts at identifying patients with inadequate bowel preparation before procedure start have been unsuccessful. While appealing because of low cost, low risk and ease of use, the appearance of fecal effluent and patient self-report have proven unreliable predictors of bowel preparation quality \[[@R16], [@R17]\]. Alternatively, the US Multi-Society Task Force recommends that preliminary assessment of preparation quality be made endoscopically in the rectosigmoid colon with termination of procedures in which the bowel preparation is inadequate to detect polyps \> 5 mm \[[@R18]\]. However, endoscopic assessment of bowel preparation still incurs substantial expense and (typically) sedation risk simply to make a determination of preparation adequacy. Several clinical prediction models have been developed to identify patients who are high risk for inadequate bowel preparation \[[@R19], [@R20]\]. However, these are more appropriately used to tailor the selection of the bowel preparation regimen, not for post-preparation assessment of adequacy.

While the results of our review suggest that pre-colonoscopy HBT is extremely promising, additional, more robust studies are needed to confirm the accuracy and feasibility of this testing strategy. Specifically, future studies should use rigorous methods, including endoscopist blinding and standardized bowel preparation scales. Future research into pre-colonoscopy breath testing should also be mindful of implementation strategies. For ease of use in practice, breath testing would ideally be done at a single time point and without the need for a carbohydrate substrate. The studies reviewed suggest that this is possible, which should be confirmed in the future. It will also be important to consider where and how breath testing can be integrated into current pre-colonoscopy practices. If breath testing is done at the time of patient arrival in the endoscopy unit, there will need to be protocols for how to administer additional purgative or reschedule the patients for another time. Breath testing at home prior to departure for the endoscopy unit has appeal, but it is unclear how this could be carried out feasibly.

Our review has several strengths and limitations. First, we used a comprehensive search strategy that included both full-text studies as well as abstracts. Additionally, we examined and reported breath testing protocols in great detail, which likely contributed to observed differences in results among studies and will be useful in guiding future studies of this topic. A notable limitation is that multiple studies were unclear in their patient selection process and endoscopist blinding. Another limitation of the review is that meta-analysis with summary estimates of results could not be conducted given the significant heterogeneity of study designs. Lastly, our results are subject to the same threats to validity that exist in the constituent studies.

In conclusion, our systematic review suggests that pre-colonoscopy hydrogen breath testing has high discriminant ability to differentiate patients with adequate versus inadequate bowel preparation, and that a range of carbohydrate substrates may be used, or even none at all. Further research in this area could potentially lead to a more proactive, effective and safer means to ensure every patient achieves adequate bowel preparation.
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